Device evidence · November 6, 2026

Read the classification order before trusting the label.

A granted De Novo request establishes a classification for a new device type. It does not, by itself, prove that a seller's model, intended use or current configuration is the device described in the order.

Three separate questions

Classification → controls → quoted configuration.

Find the exact order

Save the DEN number, device name, requester and decision date from the FDA De Novo record. The search result is an index; the detail record is the evidence.

Read the classification

Read the classification order for the generic type, class, indication and special controls. The detail record links to the order and, when available, the FDA decision summary.

Match the offer

Compare the quotation's model, version, intended use and claims. A product code or family name alone does not establish that match.

Scope guard: A De Novo classification is not a supplier endorsement, a clinical recommendation or proof of authorization in another country. Keep any missing model or labeling connection unresolved.

Worked example · historical U.S. FDA order

DEN180001: IDx-DR, with its limits attached.

The April 11, 2018 classification order is a useful reading example because it contains the device type, indications and special controls. It does not establish today's labeling, a current seller or a unit offered today.

DEN180001 · April 11, 2018

Identity and classification

Device and requester
IDx-DR · IDx, LLC
Classification
Class II · retinal diagnostic software device
Reference fields
21 CFR 886.1100 · product code PIB
Decision in the FDA detail record
Granted (DENG) · Direct request

Open FDA detail record

Order · page 1

Read the intended use separately

The order describes use by health care providers to automatically detect more than mild diabetic retinopathy in adults diagnosed with diabetes who have not previously been diagnosed with diabetic retinopathy. It specifies use with the Topcon NW400.

It identifies a prescription device. The generic device type is broader than this particular indication; do not substitute one for the other.

Read the classification order (PDF)

Unit: one historical classification order and its FDA detail record, not a count of manufacturers, sales, clinical outcomes or market size. Geography: U.S. FDA-market decision; requester location in the record is Iowa City, Iowa, United States. Consulted November 6, 2026. The location does not establish authorization in another country.

Special controls · selected examples, not the complete list

Class II is the start of the reading.

Pages 2–4 of the order set out controls for the device type. These selected examples explain why a class label alone cannot answer a buying question. They are requirements in the order, not a report that a seller's product was tested.

Software evidence
Order, control 1Software verification and validation based on a comprehensive hazard analysis, including image-acquisition hardware characteristics and cybersecurity.
Reading implicationA shared product code does not establish compatibility with any camera or software version a quotation may name.
Training and use
Order, controls 3–4A training program for quality images and human-factors validation evaluating the training's effect on user performance.
Reading implicationRetain user and image-acquisition conditions with the claim. Do not infer unrestricted consumer use.
Labeling warnings
Order, control 6(d)Warnings about screening beyond indicated uses, the need for follow-up care and the fact that the device does not treat the screened disease.
Reading implicationA screening result and a treatment claim are different. Keep the warning with any excerpt of the indication.

Read the full document: the order also addresses clinical performance, technical-specification changes and additional labeling. This selection is a reading aid, not a compliance checklist or a determination that a current device satisfies the controls.

Fictional quotation · not a real seller

“Works with any retinal camera” leaves a gap.

Suppose a quotation cites DEN180001 for an IDx-DR system “with any retinal camera.” The order identifies Topcon NW400. That historical document alone does not support the broader compatibility claim.

What you can document

DEN180001 was located. Page 1 names the indication, patient population and Topcon NW400; pages 2–4 specify controls. This does not prove that no later change exists.

What to resolve

Keep the quotation's camera model and software version. Request applicable current labeling and the official record supporting the offered configuration. A missing connection stays unresolved.

Use a precise note: “Historical De Novo order located; offered camera and software configuration not established by this order.” Do not turn a missing connection into either a current authorization or a finding of noncompliance.

A reproducible handoff

Leave the next reviewer a complete trail.

  1. Save the FDA search result and detail URL, DEN number, device name, requester and decision date.
  2. Keep the class, product code and generic type separate from the specific indication. Save the pages that describe special controls and the retrieval date.
  3. Place the quotation's model, version, intended use and claims beside those fields. Mark absent connections as unresolved.
  4. Check current labeling and the applicable U.S. requirements before relying on a historical order. A De Novo order is not proof of foreign authorization or a supplier's current inventory.

Primary sources and limits

The source, date and unit stay together.

  • FDA DEN180001 detail record — queried directly: number, device, requester, regulation, product code and decision date; links to the order and decision summary.
  • FDA DEN180001 classification order — April 11, 2018; page 1 for classification and indication, pages 2–4 for special controls. Read through a text representation, not a new current-labeling review.
  • FDA: De Novo Classification Request — pathway explanation read through a text representation. Regulatory guidance and controls are not sector statistics.

Consulted November 6, 2026. This is an informational reading example. It does not establish a current supplier, clinical performance, inventory, foreign authorization or complete history of later changes.